Relmada Therapeutics Inc Earnings

The next earnings date for Relmada Therapeutics Inc is November 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Relmada Therapeutics Inc Earnings

Report Date	Estimated Earnings Per Share
11/06/2025	$-0.45

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Relmada Therapeutics Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
05/23/2025	Before Market	$-0.58	-87.10%
03/17/2025	After Market	---	---
11/06/2024	After Market	$-0.72	-12.50%
08/07/2024	After Market	$-0.59	28.92%
05/08/2024	After Market	$-0.72	15.29%
03/19/2024	After Market	$-0.84	-1.20%
11/08/2023	After Market	$-0.73	19.78%
08/08/2023	After Market	$-0.84	6.67%
05/11/2023	After Market	$-0.87	2.25%
03/23/2023	After Market	$-1.41	-6.02%
11/10/2022	After Market	$-1.31	9.66%
08/11/2022	After Market	$-1.33	-4.72%
05/05/2022	After Market	$-1.40	-10.24%
03/23/2022	After Market	$-1.80	1.64%
11/11/2021	After Market	$-2.44	-52.50%
08/10/2021	After Market	$-1.56	-6.12%
05/12/2021	After Market	$-1.34	3.60%
03/23/2021	After Market	$-1.31	-12.93%
11/12/2020	After Market	$-1.05	-22.09%
08/12/2020	Before Market	$-0.73	-25.86%
05/15/2020	After Market	$-0.72	-71.43%
03/26/2020	After Market	$-0.39	-8.33%
11/13/2019	After Market	$-0.38	---
09/24/2019	After Market	$-0.50	---
05/15/2019	Before Market	$-0.08	---
02/13/2019	After Market	$-0.28	---
11/13/2018	After Market	$-0.27	---
09/28/2018	After Market	$-0.27	---
05/14/2018	After Market	$-0.26	---
02/12/2018	After Market	$-0.46	---
11/14/2017	After Market	$-0.31	---
09/28/2017	After Market	$-0.52	---
05/15/2017	After Market	$-0.66	---
02/10/2017	After Market	$-0.34	79.61%
11/10/2016	After Market	$-0.55	---
09/12/2016	After Market	$-1.16	-70.59%
05/09/2016	After Market	$-0.60	61.54%
02/05/2016	After Market	$-0.88	47.62%
11/06/2015	After Market	$0.36	---
09/11/2015	Before Market	$-6.12	-1,600.00%
05/19/2015	Before Market	$-0.92	---
02/13/2015	Before Market	$1.55	---
11/07/2014	Before Market	$-9.48	---

More About Relmada Therapeutics Inc

Website

https://www.relmada.com

Country

USA

Full Time Employees

Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.

“Relmada Therapeutics Inc Earnings” Can Refer to the Relmada Therapeutics Inc Earnings Date

Some people say “Relmada Therapeutics Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Relmada Therapeutics Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Relmada Therapeutics Inc Stock on the Earnings Date

If you own Relmada Therapeutics Inc stock (RLMD) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Relmada Therapeutics Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Relmada Therapeutics Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Relmada Therapeutics Inc Earnings

You can contact us any time if you would like to ask questions about Relmada Therapeutics Inc earnings or anything else related to the stock market.